Brief: Adocia says Eli Lilly terminates collaboration biochaperone Lispro
Jan 27 (Reuters) - Adocia SA ADOC.PA :
* Adocia announces termination by Eli Lilly LLY.N of
collaboration on biochaperone Lispro
* As a consequence of such decision and according to terms
of this agreement, rights that Adocia has licensed to Lilly will
revert to Adocia at no cost
Source text for Eikon: ID:nBw7pLt4Wa
Further company coverage: ADOC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Adocia SA
See all newsBrief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
Brief: Adocia H1 Operating Income EUR -8.932 Million
Brief: Adocia, Tonghua Dongbao Reports Positive Phase 3 Results For Ultra-Rapid Insulin In T2D
Brief: Adocia And Tonghua Dongbao Announce Final Dosing In Phase 3 Clinical Study Of Biochaperone® Lispro